NCT00136890View on ClinicalTrials.gov

PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers

PHASE3CompletedINTERVENTIONAL
Enrollment

337

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2008

Study Completion Date

January 31, 2013

Conditions
Non-small-cell Lung Carcinoma
Interventions
PROCEDURE

PET Imaging

Patients randomized to PET staging will undergo FDG-PET or PET-CT as well as some form of cranial imaging (CT or MRI)

Trial Locations (8)

L8N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

N6A 4G5

London Health Sciences Centre, London

L5M 2N1

Credit Valley, Mississauga

K1H 8L6

The Ottawa Hospital - General Campus, Ottawa

M1P 2T7

Scarborough Hospital, Scarborough Village

M4N 3M5

Sunnybrook/TEGH, Toronto

M5G 2C4

Toronto General Hospital, Toronto

M6R 1B5

St. Joseph's Health Care, Toronto

All Listed Sponsors
collaborator

Ontario Ministry of Health and Long Term Care

OTHER_GOV

lead

Ontario Clinical Oncology Group (OCOG)

OTHER

NCT00136890 - PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers | Biotech Hunter | Biotech Hunter